The Tolerability, Safety, and PK Characteristics of SIM1910-09 in Healthy Chinese Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a single-center, randomized, double-blind, placebo-controlled Phase I clinical study to evaluate the tolerability, safety, and pharmacokinetic characteristics of SIM1910-09 for injection after single/multiple dosing in healthy Chinese adult volunteers.
Epistemonikos ID: 8af03aee1cdf5b4ab55c130df2082750052c4d1d
First added on: May 10, 2024